The study findings indicated that BCYRN1, miR-490-3p, and POU3F2 formed a ceRNA mechanism to modulate the occurrence and progression of HCC, suggesting these can be served as potential target molecules for the management of HCC [160]. This evidence concerns the gene BCYRN1 and hepatocellular carcinoma.